Company Description
Drugs are a life-or-death business for Keryx Biopharmaceuticals. The company specializes in developing treatments for life-threatening ailments,...
Key Keryx Biopharmaceuticals Financials
| Company Type | Public - NASDAQ (GM): KERX Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $1.0 |
| 2005 Employees | 29 |
More Keryx Biopharmaceuticals Financials (11 pages)
Latest Keryx Biopharmaceuticals Jobs jobs by Indeed
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs....
Read more about Keryx Biopharmaceuticals's competition across multiple industries
Top Keryx Biopharmaceuticals Competitors
Editor-Selected Competitor List For Keryx Biopharmaceuticals
Sponsored Links
The Business DirectoryTrading Toolbox
Keryx Biopharmaceuticals Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman and CEO | Michael S. Weiss | Network | E-mail |
| VP Finance | James F. Oliviero | Network | E-mail |
More Keryx Biopharmaceuticals Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.